Twist Bioscience
Open
$59.38
Prev. Close
$59.38
High
$59.45
Low
$59.37
Market Snapshot
$3.47B
-45.3
-3.38
$330.19M
979
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 979 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The company has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The firm's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. The company has minority ownership in Atlas Data Storage, Inc.
emptyResult
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 979 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The company has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The firm's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. The company has minority ownership in Atlas Data Storage, Inc.
Recently from Cashu
Twist Bioscience: Leading Synthetic Biology Innovations and Future Growth Opportunities
Twist Bioscience: Pioneering Innovations in Synthetic Biology Twist Bioscience Corporation stands at the forefront of synthetic biology, utilizing its proprietary DNA synthesis platform to transform t…
Twist Bioscience Advances Synthetic Biology with Innovative DNA Synthesis Technology
Twist Bioscience Innovates with Groundbreaking DNA Synthesis Platform Twist Bioscience Corporation, a leader in the life sciences sector, continues to push the boundaries of synthetic biology with its…
Twist Bioscience Grants Equity Awards to Expand Workforce and Drive Innovation
Twist Bioscience Expands Workforce with Strategic Equity Awards Twist Bioscience Corporation, a leader in synthetic biology based in South San Francisco, announces a strategic move to enhance its work…
Twist Bioscience Boosts Workforce with 147,800 Equity Awards to New Hires
Twist Bioscience Expands Workforce with New Equity Awards Twist Bioscience Corporation, a prominent player in synthetic biology based in South San Francisco, is taking significant steps to enhance its…